Mucosal Delivery of Biopharmaceuticals: Biology, Challenges and Strategies
This book provides a concise and up-to-date overview of the biological features justifying the use of different human mucosa as delivery routes for biopharmaceuticals as well as the technological strategies that have been followed so far regarding the optimization of mucosal potentialities. The book...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY [u.a.]
Springer
2014
|
| Schlagworte: | |
| Online-Zugang: | TUM01 UBT01 Volltext |
| Zusammenfassung: | This book provides a concise and up-to-date overview of the biological features justifying the use of different human mucosa as delivery routes for biopharmaceuticals as well as the technological strategies that have been followed so far regarding the optimization of mucosal potentialities. The book also addresses the challenges that arise with the advent of new biopharmaceutical drugs and alternative means of administration. After a brief introduction, the first section addresses general aspects of the biology of mucosal tissues and their unique aspects towards beneficial or deleterious interactions with biopharmaceuticals and delivery systems. The second part is dedicated to the different delivery strategies that have recently been investigated for different mucosal sites. The third section describes the development and clinical applications, either factual or potential, of particular pharmaceutical delivery systems and products enclosing biopharmaceuticals for mucosal delivery. Special focus is set on the most successful case studies of recent years by field experts or those engaged in developing such solutions in a concise and practical way. The last section briefly centers on pertinent aspects about the regulatory, toxicological and market issues of mucosal delivery of biopharmaceuticals. José das Neves is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, and in the Faculty of Pharmacy, University of Porto, Portugal, where he earned a Ph.D. in Pharmaceutical Sciences. His previous work has spanned multiple aspects of the development of vaginal drug delivery systems, and his current research interests include the development of nanotechnology-based solutions for the development of anti-HIV microbicides and mucosal delivery of biopharmaceuticals. Bruno Sarmento is an affiliated researcher at INEB - Instituto de Engenharia ++ Biomédica, University of Porto, Portugal. He is also an assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. He earned a Ph.D. in Pharmaceutical Technology at the University of Porto. He has extensive work in the development of nanocarriers for the oral delivery of biopharmaceuticals-namely insulin-and the establishment of novel in vitro intestinal permeability models. His current research focuses on nanomedicines and their applications in the pharmaceutical and biomedical fields |
| Beschreibung: | 1 Online-Ressource |
| ISBN: | 9781461495246 |
| DOI: | 10.1007/978-1-4614-9524-6 |
Internformat
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV041733396 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 140313s2014 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461495246 |c Online |9 978-1-4614-9524-6 | ||
| 024 | 7 | |a 10.1007/978-1-4614-9524-6 |2 doi | |
| 035 | |a (OCoLC)871344162 | ||
| 035 | |a (DE-599)GBV779688023 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-91 | ||
| 050 | 0 | |a RS380 | |
| 082 | 0 | |a 615.19 | |
| 084 | |a VX 8552 |0 (DE-625)147830:255 |2 rvk | ||
| 084 | |a BIO 000 |2 stub | ||
| 245 | 1 | 0 | |a Mucosal Delivery of Biopharmaceuticals |b Biology, Challenges and Strategies |c José das Neves, Bruno Sarmento, ed. |
| 264 | 1 | |a New York, NY [u.a.] |b Springer |c 2014 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | 1 | |a This book provides a concise and up-to-date overview of the biological features justifying the use of different human mucosa as delivery routes for biopharmaceuticals as well as the technological strategies that have been followed so far regarding the optimization of mucosal potentialities. The book also addresses the challenges that arise with the advent of new biopharmaceutical drugs and alternative means of administration. After a brief introduction, the first section addresses general aspects of the biology of mucosal tissues and their unique aspects towards beneficial or deleterious interactions with biopharmaceuticals and delivery systems. The second part is dedicated to the different delivery strategies that have recently been investigated for different mucosal sites. The third section describes the development and clinical applications, either factual or potential, of particular pharmaceutical delivery systems and products enclosing biopharmaceuticals for mucosal delivery. Special focus is set on the most successful case studies of recent years by field experts or those engaged in developing such solutions in a concise and practical way. The last section briefly centers on pertinent aspects about the regulatory, toxicological and market issues of mucosal delivery of biopharmaceuticals. José das Neves is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, and in the Faculty of Pharmacy, University of Porto, Portugal, where he earned a Ph.D. in Pharmaceutical Sciences. His previous work has spanned multiple aspects of the development of vaginal drug delivery systems, and his current research interests include the development of nanotechnology-based solutions for the development of anti-HIV microbicides and mucosal delivery of biopharmaceuticals. Bruno Sarmento is an affiliated researcher at INEB - Instituto de Engenharia ++ | |
| 520 | 1 | |a Biomédica, University of Porto, Portugal. He is also an assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. He earned a Ph.D. in Pharmaceutical Technology at the University of Porto. He has extensive work in the development of nanocarriers for the oral delivery of biopharmaceuticals-namely insulin-and the establishment of novel in vitro intestinal permeability models. His current research focuses on nanomedicines and their applications in the pharmaceutical and biomedical fields | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Pharmaceutical technology | |
| 650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biologika |0 (DE-588)7689632-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Schleimhaut |0 (DE-588)4179718-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Biologika |0 (DE-588)7689632-8 |D s |
| 689 | 0 | 1 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
| 689 | 0 | 2 | |a Schleimhaut |0 (DE-588)4179718-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Neves, José das |e Sonstige |4 oth | |
| 700 | 1 | |a Sarmento, Bruno |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-1-4614-9523-9 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4614-9524-6 |x Verlag |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027180133 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4614-9524-6 |l TUM01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-1-4614-9524-6 |l UBT01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804152017908662273 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV041733396 |
| callnumber-first | R - Medicine |
| callnumber-label | RS380 |
| callnumber-raw | RS380 |
| callnumber-search | RS380 |
| callnumber-sort | RS 3380 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | VX 8552 |
| classification_tum | BIO 000 |
| collection | ZDB-2-SBL |
| ctrlnum | (OCoLC)871344162 (DE-599)GBV779688023 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Biologie Medizin |
| doi_str_mv | 10.1007/978-1-4614-9524-6 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04374nmm a2200541 c 4500</leader><controlfield tag="001">BV041733396</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">140313s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461495246</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4614-9524-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4614-9524-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)871344162</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV779688023</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS380</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 8552</subfield><subfield code="0">(DE-625)147830:255</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIO 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Mucosal Delivery of Biopharmaceuticals</subfield><subfield code="b">Biology, Challenges and Strategies</subfield><subfield code="c">José das Neves, Bruno Sarmento, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="1" ind2=" "><subfield code="a">This book provides a concise and up-to-date overview of the biological features justifying the use of different human mucosa as delivery routes for biopharmaceuticals as well as the technological strategies that have been followed so far regarding the optimization of mucosal potentialities. The book also addresses the challenges that arise with the advent of new biopharmaceutical drugs and alternative means of administration. After a brief introduction, the first section addresses general aspects of the biology of mucosal tissues and their unique aspects towards beneficial or deleterious interactions with biopharmaceuticals and delivery systems. The second part is dedicated to the different delivery strategies that have recently been investigated for different mucosal sites. The third section describes the development and clinical applications, either factual or potential, of particular pharmaceutical delivery systems and products enclosing biopharmaceuticals for mucosal delivery. Special focus is set on the most successful case studies of recent years by field experts or those engaged in developing such solutions in a concise and practical way. The last section briefly centers on pertinent aspects about the regulatory, toxicological and market issues of mucosal delivery of biopharmaceuticals. José das Neves is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, and in the Faculty of Pharmacy, University of Porto, Portugal, where he earned a Ph.D. in Pharmaceutical Sciences. His previous work has spanned multiple aspects of the development of vaginal drug delivery systems, and his current research interests include the development of nanotechnology-based solutions for the development of anti-HIV microbicides and mucosal delivery of biopharmaceuticals. Bruno Sarmento is an affiliated researcher at INEB - Instituto de Engenharia ++</subfield></datafield><datafield tag="520" ind1="1" ind2=" "><subfield code="a">Biomédica, University of Porto, Portugal. He is also an assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. He earned a Ph.D. in Pharmaceutical Technology at the University of Porto. He has extensive work in the development of nanocarriers for the oral delivery of biopharmaceuticals-namely insulin-and the establishment of novel in vitro intestinal permeability models. His current research focuses on nanomedicines and their applications in the pharmaceutical and biomedical fields</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biologika</subfield><subfield code="0">(DE-588)7689632-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schleimhaut</subfield><subfield code="0">(DE-588)4179718-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Biologika</subfield><subfield code="0">(DE-588)7689632-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Schleimhaut</subfield><subfield code="0">(DE-588)4179718-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neves, José das</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarmento, Bruno</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-4614-9523-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4614-9524-6</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027180133</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4614-9524-6</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4614-9524-6</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV041733396 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:04:02Z |
| institution | BVB |
| isbn | 9781461495246 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027180133 |
| oclc_num | 871344162 |
| open_access_boolean | |
| owner | DE-703 DE-91 DE-BY-TUM |
| owner_facet | DE-703 DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource |
| psigel | ZDB-2-SBL |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Springer |
| record_format | marc |
| spelling | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies José das Neves, Bruno Sarmento, ed. New York, NY [u.a.] Springer 2014 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier This book provides a concise and up-to-date overview of the biological features justifying the use of different human mucosa as delivery routes for biopharmaceuticals as well as the technological strategies that have been followed so far regarding the optimization of mucosal potentialities. The book also addresses the challenges that arise with the advent of new biopharmaceutical drugs and alternative means of administration. After a brief introduction, the first section addresses general aspects of the biology of mucosal tissues and their unique aspects towards beneficial or deleterious interactions with biopharmaceuticals and delivery systems. The second part is dedicated to the different delivery strategies that have recently been investigated for different mucosal sites. The third section describes the development and clinical applications, either factual or potential, of particular pharmaceutical delivery systems and products enclosing biopharmaceuticals for mucosal delivery. Special focus is set on the most successful case studies of recent years by field experts or those engaged in developing such solutions in a concise and practical way. The last section briefly centers on pertinent aspects about the regulatory, toxicological and market issues of mucosal delivery of biopharmaceuticals. José das Neves is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, and in the Faculty of Pharmacy, University of Porto, Portugal, where he earned a Ph.D. in Pharmaceutical Sciences. His previous work has spanned multiple aspects of the development of vaginal drug delivery systems, and his current research interests include the development of nanotechnology-based solutions for the development of anti-HIV microbicides and mucosal delivery of biopharmaceuticals. Bruno Sarmento is an affiliated researcher at INEB - Instituto de Engenharia ++ Biomédica, University of Porto, Portugal. He is also an assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. He earned a Ph.D. in Pharmaceutical Technology at the University of Porto. He has extensive work in the development of nanocarriers for the oral delivery of biopharmaceuticals-namely insulin-and the establishment of novel in vitro intestinal permeability models. His current research focuses on nanomedicines and their applications in the pharmaceutical and biomedical fields Medizin Medicine Toxicology Pharmaceutical technology Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf Biologika (DE-588)7689632-8 gnd rswk-swf Schleimhaut (DE-588)4179718-8 gnd rswk-swf Biologika (DE-588)7689632-8 s Wirkstofffreisetzung (DE-588)4190018-2 s Schleimhaut (DE-588)4179718-8 s DE-604 Neves, José das Sonstige oth Sarmento, Bruno Sonstige oth Erscheint auch als Druckausgabe 978-1-4614-9523-9 https://doi.org/10.1007/978-1-4614-9524-6 Verlag Volltext |
| spellingShingle | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies Medizin Medicine Toxicology Pharmaceutical technology Wirkstofffreisetzung (DE-588)4190018-2 gnd Biologika (DE-588)7689632-8 gnd Schleimhaut (DE-588)4179718-8 gnd |
| subject_GND | (DE-588)4190018-2 (DE-588)7689632-8 (DE-588)4179718-8 |
| title | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies |
| title_auth | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies |
| title_exact_search | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies |
| title_full | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies José das Neves, Bruno Sarmento, ed. |
| title_fullStr | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies José das Neves, Bruno Sarmento, ed. |
| title_full_unstemmed | Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies José das Neves, Bruno Sarmento, ed. |
| title_short | Mucosal Delivery of Biopharmaceuticals |
| title_sort | mucosal delivery of biopharmaceuticals biology challenges and strategies |
| title_sub | Biology, Challenges and Strategies |
| topic | Medizin Medicine Toxicology Pharmaceutical technology Wirkstofffreisetzung (DE-588)4190018-2 gnd Biologika (DE-588)7689632-8 gnd Schleimhaut (DE-588)4179718-8 gnd |
| topic_facet | Medizin Medicine Toxicology Pharmaceutical technology Wirkstofffreisetzung Biologika Schleimhaut |
| url | https://doi.org/10.1007/978-1-4614-9524-6 |
| work_keys_str_mv | AT nevesjosedas mucosaldeliveryofbiopharmaceuticalsbiologychallengesandstrategies AT sarmentobruno mucosaldeliveryofbiopharmaceuticalsbiologychallengesandstrategies |